Angiodynamics Inc (NASDAQ: ANGO) Q4 2023 earnings call dated Jul. 12, 2023 Corporate Participants: Jim Clemmer -- Chief Executive Officer Steve Trowbridge -- Chief Financial Officer
Angiodynamics Inc (ANGO) Q4 2023 Earnings Call Transcript
Categories
Medical Instruments & Supplies
AngioDynamics Inc. (ANGO) Q3 2023 Earnings Call Transcript
AngioDynamics Inc. (NASDAQ: ANGO) Q3 2023 earnings call dated Mar. 30, 2023 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
Angiodynamics Inc (ANGO) Q1 2023 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q1 2023 earnings call dated Oct. 06, 2022 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
BioLife Solutions Inc. (BLFS) Q2 2022 Earnings Call Transcript
BioLife Solutions Inc. (NASDAQ: BLFS) Q2 2022 earnings call dated Aug. 09, 2022 Corporate Participants: Troy Wichterman -- Chief Financial Officer Michael Rice -- Chairman &
Becton, Dickinson and Company (BDX) Q3 2022 Earnings Call Transcript
Becton, Dickinson and Company (NYSE: BDX) Q3 2022 earnings call dated Aug. 04, 2022 Corporate Participants: Francesca M. DeMartino -- Senior Vice
EssilorLuxottica (EL) Q2 2022 Earnings Call Transcript
EssilorLuxottica (PA: EL) Q2 2022 earnings call dated Jul. 29, 2022 Corporate Participants: Francesco Milleri -- Chairman and Chief Executive Officer Paul du Saillant -- Deputy
Intuitive Surgical, Inc. (ISRG) Q2 2022 Earnings Call Transcript
Intuitive Surgical, Inc. (NASDAQ: ISRG) Q2 2022 earnings call dated Jul. 21, 2022 Corporate Participants: Brian King -- Treasurer and Head of Investor Relations
Angiodynamics Inc (ANGO) Q4 2022 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q4 2022 earnings call dated Jul. 12, 2022 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
BioLife Solutions Inc. (BLFS) Q1 2022 Earnings Call Transcript
BioLife Solutions Inc. (NASDAQ: BLFS) Q1 2022 earnings call dated May. 09, 2022 Corporate Participants: Troy Wichterman -- Chief Financial Officer Michael Rice -- Chairman &
Intuitive Surgical Inc. (ISRG) Q1 2022 Earnings Call Transcript
Intuitive Surgical Inc. (NASDAQ: ISRG) Q1 2022 earnings call dated Apr. 21, 2022 Corporate Participants: Brian King -- Treasurer and Head of Investor Relations
Essilorluxottica (EL) Q4 2021 Earnings Call Transcript
Essilorluxottica (PA: EL) Q4 2021 earnings call dated Mar. 11, 2022 Corporate Participants: Giorgio Iannella -- Head of Investor Relations Francesco Milleri -- Chief Executive Officer
BioLife Solutions, Inc. (BLFS) Q4 2021 Earnings Call Transcript
BioLife Solutions, Inc. (NASDAQ: BLFS) Q4 2021 earnings call dated Feb. 28, 2022 Corporate Participants: Troy Wichterman -- Chief Financial Officer Michael Rice -- Chairman and
Becton, Dickinson and Company (BDX) Q1 2022 Earnings Call Transcript
Becton, Dickinson and Company (NYSE: BDX) Q1 2022 earnings call dated Feb. 03, 2022 Corporate Participants: Francesca DeMartino -- Senior Vice President and Head
Intuitive Surgical Inc. (ISRG) Q4 2021 Earnings Call Transcript
Intuitive Surgical Inc. (NASDAQ: ISRG) Q4 2021 earnings call dated Jan. 20, 2022 Corporate Participants: Brian King -- Head, Investor Relations Gary S. Guthart -- Chief
Becton, Dickinson and Company (BDX) Q4 2021 Earnings Call Transcript
Becton, Dickinson and Company (NYSE: BDX) Q4 2021 earnings call dated Nov. 04, 2021 Corporate Participants: Nadia Goncalves -- Senior Director, Investor Relations Tom
BioLife Solutions, Inc. (BLFS) Q2 2021 Earnings Call Transcript
BioLife Solutions, Inc. (NASDAQ: BLFS) Q2 2021 earnings call dated Aug. 12, 2021 Corporate Participants: Rod de Greef -- Chief Financial Officer Michael Rice -- Chief
BioLife Solutions, Inc. (BLFS) Q4 2020 Earnings Call Transcript
BioLife Solutions, Inc. (NASDAQ: BLFS) Q4 2020 earnings call dated Mar. 22, 2021 Corporate Participants: Rod de Greef -- Chief Financial Officer and Chief
AngioDynamics Inc. (ANGO) Q2 2021 Earnings Call Transcript
AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive